ANALYSIS OF THE DEVELOPMENT STRATEGY OF UNIGROUP GROUP

Main Article Content

Guonyu Dong

Abstract

       As a university-run enterprise founded by Tsinghua University 30 years ago, Unigroup Group has now become the largest comprehensive integrated circuit enterprise in China and the world's third-largest mobile phone chip enterprise. This paper analyzes Unigroup from the perspective of corporate strategy, believes that Unigroup adopts the overall related diversification strategy, combines the relevant financial indicators to analyze the strategy, and then puts forward the risk management technology and method, which is not suitable for qualitative analysis, but should take more quantitative analysis method of risk management research conclusion.

Article Details

How to Cite
Dong, G. . (2023). ANALYSIS OF THE DEVELOPMENT STRATEGY OF UNIGROUP GROUP. Journal of Buddhist Education and Research, 9(3), 241–245. Retrieved from https://so06.tci-thaijo.org/index.php/jber/article/view/271509
Section
Research Article

References

Gu L.L., Cai L. & Lei Y. (2017). Family governance, ownership change and enterprise innovation -- An Empirical Study Based on Chinese family enterprises Management Science (02), 39-53

Li, Y. X. & Hu, Y. F. (2021). Cross-border integration strategy of emerging market enterprises: research, review and outlook. Foreign Economy and Management (10), 85-102.

Liu, J. F. (2019). Research on semiconductor product marketing strategy of Unigroup Group (master's thesis, Lanzhou University of Technology).

Qiu, L. & Wang, T. Y. (2021). International board of directors and corporate strategic choices.Journal of Jilin Industry and Business School (04), 59-66.

Wang Y.N. (2011). Research on the impact of executive incentive on R & D Investment -- An Empirical Test Based on listed manufacturing companies in China. Scientific research (07),1071-1078.

Wang, L. B. (2018). Analysis of Financial Statements (Based on Harvard Analysis Framework, Master's thesis, Lanzhou University of Technology).

Wang, W. B. (2021). Financial analysis of Hengrui Pharmaceutical from the strategic perspective. Modern business (24), 110-112.